Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients
Clinical trial NCT03144947 · UNKNOWN
Trial details
- NCT number
- NCT03144947
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2021-03-15
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.